Redx shares soar after IPF drug license deal with AstraZeneca

Redx shares soar after IPF drug license deal with AstraZeneca

Source: 
Pharmaforum
snippet: 

Shares in Redx Pharma were soaring this morning after it licensed its preclinical fibrotic disease drug RXC006 to AstraZeneca.